Skip to content

Assessing donor kidneys and monitoring transplant recipients

Assessing donor kidneys and monitoring transplant recipients

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86131069
Enrollment
20
Registered
2026-02-26
Start date
2025-12-12
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult kidney transplant recipients, living kidney donors and deceased donor organ offers. Urological and Genital Diseases

Interventions

Donor organ ex-vivo MRI scans in a 3 Tesla MRI scanner: MRI measures will comprise high spatial resolution relaxometry maps (T1: ultrafast-gradient-echo
T2: GRASE
T2*: multi-shot-FFE), DWI and DTI images, and MTR data. We will perform quantitative susceptibility mapping (QSM
sensitive to cellular arrangement and tissue microstructure and collect ultra-high resolution T2*-weighted and T1-weighted images. Post-transplant MRI scans: A 3 Tesla MRI scanner at the radiology de

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Organ-offer criteria: 1. Kidney-only offer from living or deceased donors, including both Donation after Circulatory Death (DCD) or Donation after Brain Death (DBD) donors. 2. Accepted for transplantation according to standard clinical selection criteria. 3. Donor/family/next of kin consent for research. Recipient criteria: 1. Male or Female aged 18 years or above. 2. Recipient participant who is admitted as a recipient of a kidney transplant. 3. Recipient participant is willing and able to give informed consent for participation in the study.

Exclusion criteria

Exclusion criteria: Organ-offer criteria: 1. Donor organs accepted Kidney transplants which are part of any other simultaneous transplant, such as simultaneous pancreas kidney or modified multi-visceral transplants. Recipient criteria: 1. Unwilling or unable to comply with the requirements of this protocol including the presence of any condition (physical, mental, or social) that, in the opinion of the PI, is likely to affect the recipient participants ability to comply with the study protocol. 2. Recipient participant has any contraindication to MRI (including pregnancy).

Countries

England, United Kingdom

Contacts

Public ContactMaria;Edward Kaisar;Sharples

;

maria.kaisar@nds.ox.ac.uk;edward.sharples@ouh.nhs.uk+44 1865223872;+44 1865 223872

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026